Shortwave Life Sciences Plc Total Voting Rights
31 Julio 2024 - 6:05AM
RNS Regulatory News
RNS Number : 6180Y
Shortwave Life Sciences Plc
31 July 2024
31 July 2024
SHORTWAVE LIFE SCIENCES
PLC
("Shortwave", or
"the Company")
Total Voting Rights
In accordance with the Financial Conduct
Authority's Disclosure and Transparency Rules, Shortwave hereby
announces that the Company has 370,790,764 ordinary shares of
£0.001 each ("Ordinary Shares") in issue, each share carrying the
right to one vote.
The above figure of 370,790,764 Ordinary Shares
may be used by shareholders in the Company as the denominator for
the calculations by which they will determine if they are required
to notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct
Authority's Disclosure and Transparency Rules.
The directors of the Company accept
responsibility for the contents of this announcement.
Enquiries:
|
Company
|
|
|
Rivki Stern
|
+972 54 762
1621
|
|
Peterhouse
Capital Limited
|
|
|
Corporate
Adviser
|
+ 44 0 20 7469
0930
|
|
Corporate
Broker
|
+44 0 20 7220
9797
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXRBMBTMTMJBII
Shortwave Life Sciences (AQSE:PSY)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Shortwave Life Sciences (AQSE:PSY)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
